National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Bio Pharmacy > Bio Medicine > United States Biosimilar Drug Market Report 2017

United States Biosimilar Drug Market Report 2017

Goods_sn:tyj-gz3

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

United States Biosimilar Drug Market Report 2017

Hard Copy: 3800 USD
PDF Copy (single user): 3800 USD
Enterprise wide License: 7600 USD
Pages: 117
Tables and Figures: 137
Published Date: Jan 2017
Publisher: QYR Pharma & Healthcare Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

Notes:
Sales, means the sales volume of Biosimilar Drug
Revenue, means the sales value of Biosimilar Drug

This report studies sales (consumption) of Biosimilar Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    CP Guojian Pharma
    Biotech Pharma
    Celgen Pharma
    Henlius

Market Segment by States, covering
    California
    Texas
    New York
    Florida
    Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Injection
    Tablets
    Others
Split by applications, this report focuses on sales, market share and growth rate of  Biosimilar Drug in each application, can be divided into
    Ankylosing Spondylitis
    Tumor
    Rheumatoid Arthrtis
    Cardiovascular

Table of Contents

United States Biosimilar Drug Market Report 2017
1 Biosimilar Drug Overview
    1.1 Product Overview and Scope of Biosimilar Drug
    1.2 Classification of Biosimilar Drug
        1.2.1 Injection
        1.2.2 Tablets
        1.2.3 Others
    1.3 Application of Biosimilar Drug
        1.3.1 Ankylosing Spondylitis
        1.3.2 Tumor
        1.3.3 Rheumatoid Arthrtis
        1.3.4 Cardiovascular
    1.4 United States Market Size Sales (Volume) and Revenue (Value) of Biosimilar Drug (2012-2022)
        1.4.1 United States Biosimilar Drug Sales and Growth Rate (2012-2022)
        1.4.2 United States Biosimilar Drug Revenue and Growth Rate (2012-2022)

2 United States Biosimilar Drug Competition by Manufacturers
    2.1 United States Biosimilar Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
    2.2 United States Biosimilar Drug Revenue and Share by Manufactures (2015 and 2016)
    2.3 United States Biosimilar Drug Average Price by Manufactures (2015 and 2016)
    2.4 Biosimilar Drug Market Competitive Situation and Trends
        2.4.1 Biosimilar Drug Market Concentration Rate
        2.4.2 Biosimilar Drug Market Share of Top 3 and Top 5 Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion

3 United States Biosimilar Drug Sales (Volume) and Revenue (Value) by States (2012-2017)
    3.1 United States Biosimilar Drug Sales and Market Share by States (2012-2017)
    3.2 United States Biosimilar Drug Revenue and Market Share by States (2012-2017)
    3.3 United States Biosimilar Drug Price by States (2012-2017)

4 United States Biosimilar Drug Sales (Volume) and Revenue (Value) by Type (2012-2017)
    4.1 United States Biosimilar Drug Sales and Market Share by Type (2012-2017)
    4.2 United States Biosimilar Drug Revenue and Market Share by Type (2012-2017)
    4.3 United States Biosimilar Drug Price by Type (2012-2017)
    4.4 United States Biosimilar Drug Sales Growth Rate by Type (2012-2017)

5 United States Biosimilar Drug Sales (Volume) by Application (2012-2017)
    5.1 United States Biosimilar Drug Sales and Market Share by Application (2012-2017)
    5.2 United States Biosimilar Drug Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 United States Biosimilar Drug Manufacturers Profiles/Analysis
    6.1 CP Guojian Pharma
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Biosimilar Drug Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Biotech Pharma
        6.2.2 Biosimilar Drug Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Celgen Pharma
        6.3.2 Biosimilar Drug Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Henlius
        6.4.2 Biosimilar Drug Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview

7 Biosimilar Drug Manufacturing Cost Analysis
    7.1 Biosimilar Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Biosimilar Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Biosimilar Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Biosimilar Drug Market Forecast (2017-2022)
    11.1 United States Biosimilar Drug Sales, Revenue Forecast (2017-2022)
    11.2 United States Biosimilar Drug Sales Forecast by Type (2017-2022)
    11.3 United States Biosimilar Drug Sales Forecast by Application (2017-2022)
    11.4 Biosimilar Drug Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures 

    Figure Picture of Biosimilar Drug
    Table Classification of Biosimilar Drug
    Figure United States Sales Market Share of Biosimilar Drug by Type in 2015
    Figure Injection Picture
    Figure Tablets Picture
    Figure Others Picture
    Table Application of Biosimilar Drug
    Figure United States Sales Market Share of Biosimilar Drug by Application in 2015
    Figure Ankylosing Spondylitis Examples
    Figure Tumor Examples
    Figure Rheumatoid Arthrtis Examples
    Figure Cardiovascular Examples
    Figure United States Biosimilar Drug Sales and Growth Rate (2012-2022)
    Figure United States Biosimilar Drug Revenue and Growth Rate (2012-2022)
    Table United States Biosimilar Drug Sales of Key Manufacturers (2015 and 2016)
    Table United States Biosimilar Drug Sales Share by Manufacturers (2015 and 2016)
    Figure 2015 Biosimilar Drug Sales Share by Manufacturers
    Figure 2016 Biosimilar Drug Sales Share by Manufacturers
    Table United States Biosimilar Drug Revenue by Manufacturers (2015 and 2016)
    Table United States Biosimilar Drug Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 United States Biosimilar Drug Revenue Share by Manufacturers
    Table 2016 United States Biosimilar Drug Revenue Share by Manufacturers
    Table United States Market Biosimilar Drug Average Price of Key Manufacturers (2015 and 2016)
    Figure United States Market Biosimilar Drug Average Price of Key Manufacturers in 2015
    Figure Biosimilar Drug Market Share of Top 3 Manufacturers
    Figure Biosimilar Drug Market Share of Top 5 Manufacturers
    Table United States Biosimilar Drug Sales by States (2012-2017)
    Table United States Biosimilar Drug Sales Share by States (2012-2017)
    Figure United States Biosimilar Drug Sales Market Share by States in 2015
    Table United States Biosimilar Drug Revenue and Market Share by States (2012-2017)
    Table United States Biosimilar Drug Revenue Share by States (2012-2017)
    Figure Revenue Market Share of Biosimilar Drug by States (2012-2017)
    Table United States Biosimilar Drug Price by States (2012-2017)
    Table United States Biosimilar Drug Sales by Type (2012-2017)
    Table United States Biosimilar Drug Sales Share by Type (2012-2017)
    Figure United States Biosimilar Drug Sales Market Share by Type in 2015
    Table United States Biosimilar Drug Revenue and Market Share by Type (2012-2017)
    Table United States Biosimilar Drug Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Biosimilar Drug by Type (2012-2017)
    Table United States Biosimilar Drug Price by Type (2012-2017)
    Figure United States Biosimilar Drug Sales Growth Rate by Type (2012-2017)
    Table United States Biosimilar Drug Sales by Application (2012-2017)
    Table United States Biosimilar Drug Sales Market Share by Application (2012-2017)
    Figure United States Biosimilar Drug Sales Market Share by Application in 2015
    Table United States Biosimilar Drug Sales Growth Rate by Application (2012-2017)
    Figure United States Biosimilar Drug Sales Growth Rate by Application (2012-2017)
    Table CP Guojian Pharma Basic Information List
    Table CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
    Figure CP Guojian Pharma Biosimilar Drug Sales Market Share (2012-2017)
    Table Biotech Pharma Basic Information List
    Table Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Biotech Pharma Biosimilar Drug Sales Market Share (2012-2017)
    Table Celgen Pharma Basic Information List
    Table Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Celgen Pharma Biosimilar Drug Sales Market Share (2012-2017)
    Table Henlius Basic Information List
    Table Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Henlius Biosimilar Drug Sales Market Share (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Biosimilar Drug
    Figure Manufacturing Process Analysis of Biosimilar Drug
    Figure Biosimilar Drug Industrial Chain Analysis
    Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
    Table Major Buyers of Biosimilar Drug
    Table Distributors/Traders List
    Figure United States Biosimilar Drug Production and Growth Rate Forecast (2017-2022)
    Figure United States Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)
    Table United States Biosimilar Drug Production Forecast by Type (2017-2022)
    Table United States Biosimilar Drug Consumption Forecast by Application (2017-2022)
    Table United States Biosimilar Drug Sales Forecast by States (2017-2022)
    Table United States Biosimilar Drug Sales Share Forecast by States (2017-2022)

Request sample If you need any reports sample, just let us know.